Number of the records: 1
Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors
Title Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors Author Čierna Zuzana Co-authors Mego Michal Miškovská V. Machaleková K. Chovanec Michal Svetlovská D. Kaľavská Katarína 1987- SAVEXONK - Ústav experimentálnej onkológie SAV Rejleková Katarína Macák Demián Špánik Stanislav Ondruš Dalibor Kajo Karol ORCID Mardiak Jozef Babál Pavel Source document Annals of oncology. Vol. 27, no. 2 (2016), p. 300-305 Language eng - English Document kind rozpis článkov z periodík (rbx) Citations HAN, C. - ZHOU, Y. - MA, J.A. - LIU, J. - JIANG, Y.N. - ZHANG, H.X. A promising treatment option for refractory male primary choriocarcinoma: report of two cases. In TRANSLATIONAL CANCER RESEARCH. ISSN 2218-676X, APR 2020, vol. 9, no. 4, p. 3054-3060. CHIEFFI, P. - DE MARTINO, M. - ESPOSITO, F. Further insights into testicular germ cell tumor oncogenesis: potential therapeutic targets. In EXPERT REVIEW OF ANTICANCER THERAPY. ISSN 1473-7140, MAR 3 2020, vol. 20, no. 3, p. 189-195. LOBO, J. - JERONIMO, C. - HENRIQUE, R. Targeting the Immune system and Epigenetic Landscape of Urological Tumors. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. FEB 2020, vol. 21, no. 3. NECCHI, A. - BRATSLAVSKY, G. - CORONA, R.J. - CHUNG, J.H. - MILLIS, S.Z. - ELVIN, J.A. - VERGILIO, J.A. - SUH, J. - RAMKISSOON, S. - SEVERSON, E. - DANIEL, S. - KILLIAN, J.K. - ALI, S.M. - SCHROCK, A.B. - REDDY, P. - MILLER, V.A. - WELSH, A. - GAY, L.M. - ROSS, J.S. Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy. In EUROPEAN UROLOGY FOCUS. JAN 15 2020, vol. 6, no. 1, p. 122-130. JIANG, H. - ZHANG, R.J. - JIANG, H.J. - ZHANG, M.Y. - GUO, W. - ZHANG, J.F. - ZHOU, X.L. - PAN, W.B. - ZHAO, S. - LI, P. Retrospective analysis of the prognostic value of PD-L1 expression and F-18-FDG PET/CT metabolic parameters in colorectal cancer. In JOURNAL OF CANCER. ISSN 1837-9664, 2020, vol. 11, no. 10, p. 2864-2873. NISHIMOTO, M. - OHARA, K. - KAMAMOTO, D. - TAMURA, R. - MIWA, T. - YOSHIDA, K. - SASAKI, H. Tumor immune microenvironment is associated with the growth of intracranial germinomas. In JOURNAL OF NEURO-ONCOLOGY. ISSN 0167-594X, JAN 2020, vol. 146, no. 1, p. 139-146. GALVEZ-CARVAJAL, L. - SANCHEZ-MUNOZ, A. - RIBELLES, N. - SAEZ, M. - BAENA, J. - RUIZ, S. - ITHURBISQUY, C. - ALBA, E. Targeted treatment approaches in refractory germ cell tumors. In CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. ISSN 1040-8428, NOV 2019, vol. 143, p. 130-138. DE GIORGI, U. - CASADEI, C. - BERGAMINI, A. - ATTADEMO, L. - CORMIO, G. - LORUSSO, D. - PIGNATA, S. - MANGILI, G. Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors. In CANCERS. OCT 2019, vol. 11, no. 10. LOBO, J. - RODRIGUES, A. - GUIMARAES, R. - CANTANTE, M. - LOPES, P. - MAURICIO, J. - OLIVEIRA, J. - JERONIMO, C. - HENRIQUE, R. Detailed Characterization of Immune Cell Infiltrate and Expression of Immune Checkpoint Molecules PD-L1/CTLA-4 and MMR Proteins in Testicular Germ Cell Tumors Disclose Novel Disease Biomarkers. In CANCERS. OCT 2019, vol. 11, no. 10. SCHEPISI, G. - BRIGHI, N. - CURSANO, M.C. - GURIOLI, G. - RAVAGLIA, G. - ALTAVILLA, A. - BURGIO, S.L. - TESTONI, S. - MENNA, C. - FAROLFI, A. - CASADEI, C. - TONINI, G. - SANTINI, D. - DE GIORGI, U. Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors. In JOURNAL OF ONCOLOGY. ISSN 1687-8450, SEP 19 2019, vol. 2019. HINSCH, A. - BLESSIN, N.C. - SIMON, R. - KLUTH, M. - FISCHER, K. - HUBE-MAGG, C. - LI, W.C. - MAKRYPIDI-FRAUNE, G. - WELLGE, B. - MANDELKOW, T. - DEBATIN, N.F. - HOFLMAYER, D. - LENNARTZ, M. - SAUTER, G. - IZBICKI, J.R. - MINNER, S. - BUSCHECK, F. - UHLIG, R. - DUM, D. - KRECH, T. - LUEBKE, A.M. - WITTMER, C. - JACOBSEN, F. - BURANDT, E. - STEURER, S. - WILCZAK, W. Expression of the immune checkpoint receptor TIGIT in seminoma. In ONCOLOGY LETTERS. ISSN 1792-1074, AUG 2019, vol. 18, no. 2, p. 1497-1502. QIU, Z.H. - WU, Y.Q. - WANG, Y.P. - HU, C.H. Male primary mediastinal choriocarcinoma with diffuse metastases A case report. In MEDICINE. ISSN 0025-7974, JUL 2019, vol. 98, no. 28. LAFIN, J.T. - BAGRODIA, A. - WOLDU, S. - AMATRUDA, J.F. New insights into germ cell tumor genomics. In ANDROLOGY. ISSN 2047-2919, JUL 2019, vol. 7, no. 4, SI, p. 507-515. ALSDORF, W. - SEIDEL, C. - BOKEMEYER, C. - OING, C. Current pharmacotherapy for testicular germ cell cancer. In EXPERT OPINION ON PHARMACOTHERAPY. ISSN 1465-6566, MAY 3 2019, vol. 20, no. 7, p. 837-850. NI, X. - SUN, X. - WANG, D. - CHEN, Y. - ZHANG, Y. - LI, W. - WANG, L. - SUO, J. The clinicopathological and prognostic value of programmed death-ligand 1 in colorectal cancer: a meta-analysis. In CLINICAL & TRANSLATIONAL ONCOLOGY. ISSN 1699-048X, MAY 2019, vol. 21, no. 5, p. 674-686. BATOOL, A. - KARIMI, N. - WU, X.N. - CHEN, S.R. - LIU, Y.X. Testicular germ cell tumor: a comprehensive review. In CELLULAR AND MOLECULAR LIFE SCIENCES. ISSN 1420-682X, MAY 2019, vol. 76, no. 9, p. 1713-1727. ROSTI, G. - SECONDINO, S. - NECCHI, A. - FORNARINI, G. - PEDRAZZOLI, P. Primary mediastinal germ cell tumors. In SEMINARS IN ONCOLOGY. ISSN 0093-7754, APR 2019, vol. 46, no. 2, p. 107-111. WANG, L.L. - LI, Z.H. - DUAN, Y.G. - YUAN, S.Q. - MOR, G. - LIAO, A.H. Identification of programmed cell death 1 and its ligand in the testicular tissue of mice. In AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY. ISSN 1046-7408, FEB 2019, vol. 81, no. 2. LI, Y.Q. - WANG, G. - CHENG, X.F. Gastric yolk sac tumor with synchronous liver metastasis: first case report in China. In TRANSLATIONAL CANCER RESEARCH. ISSN 2218-676X, FEB 2019, vol. 8, no. 1, p. 338-342. SEMAAN, A. - HADDAD, F.G.H. - EID, R. - KOURIE, H.R. - NEMR, E. Immunotherapy: last bullet in platinum refractory germ cell testicular cancer. In FUTURE ONCOLOGY. ISSN 1479-6694, FEB 2019, vol. 15, no. 5, p. 533-541. PARIMI, S. - RAUW, J.M. - KO, J.J. Systemic Therapies for Metastatic Testicular Germ Cell Tumors: Past, Present and Future. In CURRENT CANCER THERAPY REVIEWS. ISSN 1573-3947, 2019, vol. 15, no. 2, p. 86-99. BOLDRINI, R. - DE PASQUALE, M.D. - MELAIU, O. - CHIERICI, M. - JURMAN, G. - BENEDETTI, M.C. - SALFI, N.C. - CASTELLANO, A. - COLLINI, P. - FURLANELLO, C. - PISTOIA, V. - CIFALDI, L. - TERENZIANI, M. - FRUCI, D. Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors. In ONCOIMMUNOLOGY. ISSN 2162-402X, 2019, vol. 8, no. 2. NECCHI, A. - GIANNATEMPO, P. - RAGGI, D. - MARIANI, L. - COLECCHIA, M. - FARE, E. - MONOPOLI, F. - CALARESO, G. - ALI, S.M. - ROSS, J.S. - CHUNG, J.H. - SALVIONI, R. An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis. In EUROPEAN UROLOGY. ISSN 0302-2838, JAN 2019, vol. 75, no. 1, p. 201-203. DE LARA, P.T. - CECCONI, V. - HILTBRUNNER, S. - YAGITA, H. - FRIESS, M. - BODE, B. - OPITZ, I. - VRUGT, B. - WEDER, W. - STOLZMANN, P. - FELLEY-BOSCO, E. - STAHEL, R.A. - TISCHLER, V. - BRITSCHGI, C. - SOLDINI, D. - VAN DEN BROEK, M. - CURIONI-FONTECEDRO, A. Gemcitabine Synergizes with Immune Checkpoint Inhibitors and Overcomes Resistance in a Preclinical Model and Mesothelioma Patients. In CLINICAL CANCER RESEARCH. ISSN 1078-0432, DEC 15 2018, vol. 24, no. 24, p. 6345-6354. PEDRAZA, A.M. - STEPHENSON, A.J. Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours. In CURRENT OPINION IN UROLOGY. ISSN 0963-0643, SEP 2018, vol. 28, no. 5, p. 448-453. OING, C. - BOKEMEYER, C. Biological basis and early clinical results of immunotherapy for cisplatin-resistant germ cell cancer. In CURRENT OPINION IN UROLOGY. ISSN 0963-0643, SEP 2018, vol. 28, no. 5, p. 479-484. JENNEWEIN, L. - BARTSCH, G. - GUST, K. - KVASNICKA, H.M. - HAFERKAMP, A. - BLAHETA, R. - MITTELBRONN, M. - HARTER, P.N. - MANI, J. Increased tumor vascularization is associated with the amount of immune competent PD-1 positive cells in testicular germ cell tumors. In ONCOLOGY LETTERS. ISSN 1792-1074, JUN 2018, vol. 15, no. 6, p. 9852-9860. CHAHOUD, J. - ZHANG, M. - SHAH, A. - LIN, S.H. - PISTERS, L.L. - TU, S.M. Managing seminomatous and nonseminomatous germ cell tumors. In CURRENT OPINION IN ONCOLOGY. ISSN 1040-8746, MAY 2018, vol. 30, no. 3, p. 181-188. LIU, B. - ARAKAWA, Y. - YOKOGAWA, R. - TOKUNAGA, S. - TERADA, Y. - MURATA, D. - MATSUI, Y. - FUJIMOTO, K. - FUKUI, N. - TANJI, M. - MINEHARU, Y. - MINAMIGUCHI, S. - MIYAMOTO, S. PD-1/PD-L1 expression in a series of intracranial germinoma and its association with Foxp3+and CD8+infiltrating lymphocytes. In PLOS ONE. ISSN 1932-6203, APR 4 2018, vol. 13, no. 4. WILDEMAN, M.E. - SHEPARD, M.J. - OLDFIELD, E.H. - LOPES, M.B.S. Central Nervous System Germinomas Express Programmed Death Ligand 1. In JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. ISSN 0022-3069, APR 2018, vol. 77, no. 4, p. 312-316. ZAPKA, P. - DORNER, E. - DRESCHMANN, V. - SAKAMATO, N. - KRISTIANSEN, G. - CALAMINUS, G. - VOKUHL, C. - LEUSCHNER, I. - PIETSCH, T. Type, Frequency, and Spatial Distribution of Immune Cell Infiltrates in CNS Germinomas: Evidence for Inflammatory and Immunosuppressive Mechanisms. In JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. ISSN 0022-3069, FEB 2018, vol. 77, no. 2, p. 119-127. KALLERGI, G. - VETSIKA, E.K. - AGGOURAKI, D. - LAGOUDAKI, E. - KOUTSOPOULOS, A. - KOINIS, F. - KATSARLINOS, P. - TRYPAKI, M. - MESSARITAKIS, I. - STOURNARAS, C. - GEORGOULIAS, V. - KOTSAKIS, A. Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer. In THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. ISSN 1758-8340, JAN 15 2018, vol. 10. KOLLMANNSBERGER, C. - NAPPI, L. - NICHOLS, C. Novel treatment options for refractory Germ Cell Tumours: back to the bench!. In ANNALS OF ONCOLOGY. ISSN 0923-7534, JAN 2018, vol. 29, no. 1, p. 21-22. ADRA, N. - EINHORN, L.H. - ALTHOUSE, S.K. - AMMAKKANAVAR, N.R. - MUSAPATIKA, D. - ALBANY, C. - VAUGHN, D. - HANNA, N.H. Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206. In ANNALS OF ONCOLOGY. ISSN 0923-7534, JAN 2018, vol. 29, no. 1, p. 209-214. OING, C. - SEIDEL, C. - BOKEMEYER, C. Therapeutic approaches for refractory germ cell cancer. In EXPERT REVIEW OF ANTICANCER THERAPY. ISSN 1473-7140, 2018, vol. 18, no. 4, p. 389-397. ZHANG, M.H. - LI, G.L. - WANG, Y.B. - YAN, W. - SHU, Z. - PU, H. - ZHAO, H.L. - WANG, Y. PD-L1 expression in lung cancer and its correlation with driver mutations: a meta-analysis. In SCIENTIFIC REPORTS. ISSN 2045-2322, AUG 31 2017, vol. 7. ZHANG, M.H. - WANG, D.L. - SUN, Q. - PU, H.H. - WANG, Y. - ZHAO, S. - WANG, Y. - ZHANG, Q.Y. Prognostic significance of PD-L1 expression and F-18-FDG PET/CT in surgical pulmonary squamous cell carcinoma. In ONCOTARGET. AUG 1 2017, vol. 8, no. 31, p. 51630-51640. WANG, L.L. - LI, Z.H. - HU, X.H. - MUYAYALO, K.P. - ZHANG, Y.H. - LIAO, A.H. The roles of the PD-1/PD-L1 pathway at immunologically privileged sites. In AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY. ISSN 1046-7408, AUG 2017, vol. 78, no. 2, SI. ZHANG, M.H. - SUN, H.B. - ZHAO, S. - WANG, Y. - PU, H.H. - WANG, Y. - ZHANG, Q.Y. Expression of PD-L1 and prognosis in breast cancer: a meta-analysis. In ONCOTARGET. MAY 9 2017, vol. 8, no. 19, p. 31347-31354. ZSCHABITZ, S. - LASITSCHKA, F. - HADASCHIK, B. - HOFHEINZ, R.D. - JENTSCH-ULLRICH, K. - GRUNER, M. - JAGER, D. - GRULLICH, C. Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation. In EUROPEAN JOURNAL OF CANCER. ISSN 0959-8049, MAY 2017, vol. 76, p. 1-7. MSAOUEL, P. - BILEN, M.A. - ZHANG, M. - CAMPBELL, M. - WANG, J. - TU, S.M. Recent developments in the management of germ cell tumors. In CURRENT OPINION IN ONCOLOGY. ISSN 1040-8746, MAY 2017, vol. 29, no. 3, p. 172-178. MEHTA, K. - PATEL, K. - PARIKH, R.A. Immunotherapy in genitourinary malignancies. In JOURNAL OF HEMATOLOGY & ONCOLOGY. APR 24 2017, vol. 10. VERKARRE, V. - ROUSSEL, H. - GRANIER, C. - TARTOUR, E. - ALLORY, Y. Immunotherapy in uropathology. In ANNALES DE PATHOLOGIE. ISSN 0242-6498, FEB 2017, vol. 37, no. 1, p. 90-100. OING, C. - SEIDEL, C. - ALSDORF, W.H. - BOKEMEYER, C. Cisplatin-refractory germ cell tumors. Resistance mechanisms - therapy standards - new developments. In ONKOLOGE. ISSN 0947-8965, FEB 2017, vol. 23, no. 2, p. 123-128. SISKA, P.J. - JOHNPULLE, R.A.N. - ZHOU, A. - BORDEAUX, J. - KIM, J.Y. - DABBAS, B. - DAKAPPAGARI, N. - RATHMELL, J.C. - RATHMELL, W.K. - MORGANS, A.K. - BALKO, J.M. - JOHNSON, D.B. Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling. In ONCOIMMUNOLOGY. ISSN 2162-402X, 2017, vol. 6, no. 4. MANN, S.A. - LOPEZ-BELTRAN, A. - MASSARI, F. - PILI, R. - FIORENTINO, M. - KOCH, M.O. - KAIMAKLIOTIS, H.Z. - WANG, L.S. - SCARPELLI, M. - CICCARESE, C. - MOCH, H. - MONTIRONI, R. - CHENG, L. Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives. In CURRENT DRUG METABOLISM. ISSN 1389-2002, 2017, vol. 18, no. 8, p. 700-711. LOH, K.P. - FUNG, C. Novel therapies in platinum-refractory metastatic germ cell tumor: a case report with a focus on a PD-1 inhibitor. In RARE TUMORS. ISSN 2036-3605, 2017, vol. 9, no. 2, p. 47-49. ZHANG, M.H. - DONG, Y.D. - LIU, H.T. - WANG, Y. - ZHAO, S. - XUAN, Q.J. - WANG, Y. - ZHANG, Q.Y. The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients. In SCIENTIFIC REPORTS. ISSN 2045-2322, NOV 28 2016, vol. 6. SHAH, S. - WARD, J.E. - BAO, R.Y. - HALL, C.R. - BROCKSTEIN, B.E. - LUKE, J.J. Clinical Response of a Patient to Anti-PD-1 Immunotherapy and the Immune Landscape of Testicular Germ Cell Tumors. In CANCER IMMUNOLOGY RESEARCH. ISSN 2326-6066, NOV 2016, vol. 4, no. 11, p. 903-909. SELLE, F. - GLIGOROV, J. - SOARES, D.G. - LOTZ, J.P. High-dose chemotherapy as a strategy to overcome drug resistance in solid tumors. In BULLETIN DU CANCER. ISSN 0007-4551, OCT 2016, vol. 103, no. 10, p. 861-868. TAKAHASHI, N. - IWASA, S. - SASAKI, Y. - SHOJI, H. - HONMA, Y. - TAKASHIMA, A. - OKITA, N.T. - KATO, K. - HAMAGUCHI, T. - YAMADA, Y. Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer. In JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. ISSN 0171-5216, AUG 2016, vol. 142, no. 8, p. 1727-1738. CATTRINI, C. - DELLEPIANE, C. - CAVO, A. - BUZZATTI, G. - TOLOMEO, F. - MESSINA, C. - BOCCARDO, F. Immunotherapy for genitourinary cancer: state of the art and new perspectives. In ANTI-CANCER DRUGS. ISSN 0959-4973, AUG 2016, vol. 27, no. 7, p. 585-599. ZSCHABITZ, S. - LASITSCHKA, F. - JAGER, D. - GRULLICH, C. Activity of immune checkpoint inhibition in platinum refractory germ-cell tumors. In ANNALS OF ONCOLOGY. ISSN 0923-7534, JUL 2016, vol. 27, no. 7, p. 1356-1360. LI, B. - JIANG, Q.Q. - ZHANG, S.T. - ZHOU, Y. - ZHANG, Q.F. - OUYANG, L. Primary yolk sac tumor of the gluteus: a case report and literature review. In ONCOTARGETS AND THERAPY. ISSN 1178-6930, 2016, vol. 9, p. 4715-4719. OING, C. - KOLLMANNSBERGER, C. - OECHSLE, K. - BOKEMEYER, C. Investigational targeted therapies for the treatment of testicular germ cell tumors. In EXPERT OPINION ON INVESTIGATIONAL DRUGS. ISSN 1354-3784, 2016, vol. 25, no. 9, p. 1033-1043. KRUSLIN, B. - GATALICA, Z. - HES, O. - SKENDERI, F. - MIETTINEN, M. - CONTRERAS, E. - XIU, J. - ELLIS, M. - FLORENTO, E. - VRANIC, S. - SWENSEN, J. TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors. In CLINICAL GENITOURINARY CANCER. ISSN 1558-7673, AUG 2021, vol. 19, no. 4, p. 333-338. LIU, Z. - SUN, L. - CAI, L. - GUO, M. - XU, G.H. - LIU, S.S. - ZHENG, G.Z. - WANG, Q. - LIAN, X. - FENG, F. - ZHANG, H.W. Clinicopathological and prognostic values of PD-L1 expression in oesophageal squamous cell carcinoma: a meta-analysis of 31 studies with 5368 patients. In POSTGRADUATE MEDICAL JOURNAL. ISSN 0032-5473. ARRU, C. - DE MIGLIO, M.R. - COSSU, A. - MURONI, M.R. - CARRU, C. - ZINELLU, A. - PALIOGIANNIS, P. Durvalumab Plus Tremelimumab in Solid Tumors: A Systematic Review. In ADVANCES IN THERAPY. ISSN 0741-238X, JUL 2021, vol. 38, no. 7, p. 3674-3693. PEZESHKI, P.S. - SHARIF, P.M. - REZAEI, N. Resistance mechanisms to programmed cell death protein 1 and programmed death ligand 1 inhibitors. In EXPERT OPINION ON BIOLOGICAL THERAPY. ISSN 1471-2598, DEC 2 2021, vol. 21, no. 12, p. 1575-1590. STEPHENS, S. - KUCHEL, A. - CHEUK, R. - ALEXANDER, H. - ROBERTSON, T. - RAJAH, T. - TRAN, Q. - INGLIS, P.L. Management trends and outcomes of pineal germinoma in a multi-institutional Australian cohort. In JOURNAL OF CLINICAL NEUROSCIENCE. ISSN 0967-5868, AUG 2021, vol. 90, p. 1-7. AL-HOGBANI, M. - DUGUAY, J. - WAGNER, D.C. - HAFERKAMP, A. - JOUBERT, P. - FREES, S. - RENDON, R. - POWER, N. - PERIGNY, M. - TOREN, P. Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumors. In UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. ISSN 1078-1439, MAY 2021, vol. 39, no. 5. CIMADAMORE, A. - RIZZO, A. - MOLLICA, V. - MASSARI, F. - LOPEZ-BELTRAN, A. - SCARPELLI, M. - CHENG, L. - SANTONI, M. - MONTIRONI, R. An update on immunotherapy in uro-oncology. In EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT. ISSN 2380-8993, JUL 4 2021, vol. 6, no. 4, p. 229-233. PEKSA, R. - KUNC, M. - POPEDA, M. - PIATEK, M. - BIENKOWSKI, M. - ZOK, J. - STARZYNSKA, A. - PERDYAN, A. - SOWA, M. - DUCHNOWSKA, R. - BIERNAT, W. Combined Assessment of Immune Checkpoint Regulator VISTA on Tumor-Associated Immune Cells and Platelet-to-Lymphocyte Ratio Identifies Advanced Germ Cell Tumors with Higher Risk of Unfavorable Outcomes. In CANCERS. APR 2021, vol. 13, no. 8. TSIMBERIDOU, A.M. - VO, H.H. - SUBBIAH, V. - JANKU, F. - PIHA-PAUL, S. - YILMAZ, B. - GONG, J. - NAQVI, M.F. - TU, S.M. - CAMPBELL, M. - MERIC-BERNSTAM, F. - NAING, A. Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors. In ONCOLOGIST. ISSN 1083-7159, JUL 2021, vol. 26, no. 7, p. 558-+. KAWAI, K. - TAWADA, A. - ONOZAWA, M. - INOUE, T. - SAKURAI, H. - MORI, I. - TAKIGUCHI, Y. - MIYAZAKI, J. Rapid Response to Pembrolizumab in a Chemo-Refractory Testicular Germ Cell Cancer with Microsatellite Instability-High. In ONCOTARGETS AND THERAPY. ISSN 1178-6930, 2021, vol. 14, p. 4853-4858. WOODS, J.K. - LIDOV, H.G. - LIGON, K.L. - SANTAGATA, S. - CHI, S.N. - YEO, K.K. - ALEXANDRESCU, S. PD-L1 and PD-1 expression in pediatric central nervous system germ cell tumors. In MODERN PATHOLOGY. ISSN 0893-3952, DEC 2022, vol. 35, no. 12, p. 1770-1774. Dostupné na: https://doi.org/10.1038/s41379-022-01142-3. GUO, F. - WANG, H.B. - XIA, H.S. - SHI, H.W. - XU, P. - PI, G.L. Lymph node metastasis as the initial symptom of a germ cell tumor in an adult: A case report. In MEDICINE. ISSN 0025-7974, JUL 29 2022, vol. 101, no. 30. Dostupné na: https://doi.org/10.1097/MD.0000000000029281. HAMED, M.M. - GOUIDA, M.S. - ABD EL-AZIZ, S.R. - EL-SOKKARY, A.M.A. Evaluation PD-L1, CD8 and CD20 as early predictor and tracking markers for breast cancer (BC) in Egypt. In HELIYON. MAY 2022, vol. 8, no. 5. Dostupné na: https://doi.org/10.1016/j.heliyon.2022.e09474. KAWAHARA, T. - KAWAI, K. - KOJIMA, T. - NAGUMO, Y. - SAKKA, S. - KANDORI, S. - NEGORO, H. - MATHIS, B.J. - MARUO, K. - MIURA, K. - SAKAMOTO, N. - SHINOHARA, N. - YAMASHITA, S. - YONEMORI, K. - KISHIDA, T. - UKIMURA, O. - NISHIMURA, K. - KOBAYASHI, Y. - NISHIYAMA, H. Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumors. In INTERNATIONAL JOURNAL OF UROLOGY. ISSN 0919-8172, JUL 2022, vol. 29, no. 7, p. 741-747. Dostupné na: https://doi.org/10.1111/iju.14885. VELADO-EGUSKIZA, A. - GOMEZ-SANTOS, L. - BADIOLA, I. - SAEZ, F.J. - ALONSO, E. Testicular Germ Cell Tumours and Proprotein Convertases. In CANCERS. APR 2022, vol. 14, no. 7. Dostupné na: https://doi.org/10.3390/cancers14071633. SALEH, R.R. - SCOTT, J.L. - METI, N. - PERLON, D. - FAZELZAD, R. - OCANA, A. - AMIR, E. Prognostic Value of Programmed Death Ligand-1 Expression in Solid Tumors Irrespective of Immunotherapy Exposure: A Systematic Review and Meta-Analysis. In MOLECULAR DIAGNOSIS & THERAPY. ISSN 1177-1062, MAR 2022, vol. 26, no. 2, p. 153-168. Dostupné na: https://doi.org/10.1007/s40291-022-00576-4. Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2016 Registered in WOS Registered in SCOPUS Registered in CCC DOI 10.1093/annonc/mdv574 
article
rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2016 2015 9.269 Q1 4.337 Q1
Number of the records: 1